We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026
20 Aug 2026 - 22 Aug 2026

Reflectance Oximeter Can Be Used on Flat Surfaces

By HospiMedica staff writers
Posted on 13 May 2003
A new pulse oximeter, which functions on flat surfaces, utilizes a proprietary method of multi-path light reflection to provide continuous monitoring of pulsatile oxygen saturation levels in hospitalized patients. More...
The oximeter has been cleared for use on the adult forehead by the US Food and Drug Administration (FDA).

The technology employs three wavelengths of light and two concentric photo detectors to identify pulse oxygenation and is unique because it can function on a flat surface. Called PRO2, the oximeter was developed by Imagyn Medical Technologies, Inc. (Irvine, CA, USA). The company will seek additional clearances for chest or back placement on patients. Back placement may be especially useful for operating room and neonatal intensive care use, offering comfort and convenience for an awake patient, in contrast to a conventional finger sensor, noted Imagyn.

In development is an intrapartum version that can be used for fetal pulse oximetry monitoring during labor. The flat PRO2 sensor will be touched to the presenting fetal scalp to assess oxygenation status. Feasibility testing has proven that the device is applicable through cervical dilations under 2 cm, amniotic membranes, and fetal hair. Imagyn believes the technology offers obstetricians a truly noninvasive method for oximetry monitoring and enhanced clinical assessment of the baby during birth.

"PRO2 promises to redefine pulse oximetry with advanced reflectance technology that uniquely allows core body placement of the sensor for consistent measurements and improved patient management,” said Charles A. Laverty, president and CEO of Imagyn.




Related Links:
Imagyn

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.